Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Colleoni

Showing results (101-110 of 178) with videos related to

Pageof 18
Sort By:
Annals of Surgical Oncology|May 22, 2020
Contralateral Axillary Lymph Node Metastases from Breast Carcinoma: Is it Time to Review TNM Cancer Staging?Francesca Magnoni, M Colleoni, D Mattar, et al.
British Journal of Cancer|August 23, 2007
Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancerR Torrisi, V Bagnardi, G Pruneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptorsM Colleoni, I Minchella, G Mazzarol, et al.
Breast Cancer Research and Treatment|April 3, 2012
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancerElisabetta Munzone, E Botteri, A Sciandivasci, et al.
ESMO Open|October 16, 2025
Real-world safety and efficacy profiles of trastuzumab deruxtecan in patients with advanced breast cancerG Antonarelli, M Milano, C Andreon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2009
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancerM Colleoni, V Bagnardi, N Rotmensz, et al.
British Journal of Cancer|May 29, 2008
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancerE Montagna, V Bagnardi, N Rotmensz, et al.
Annals of Surgical Oncology|December 18, 2014
Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of OncologyM Intra, G Viale, J Vila, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levelsM Colleoni, A Rocca, M T Sandri, et al.
Breast Cancer Research and Treatment|November 9, 2011
Prognostic role of CA15.3 in 7942 patients with operable breast cancerM T Sandri, M Salvatici, E Botteri, et al.
Pageof 18

Showing results (101-110 of 178) with videos related to

Sort By:
Pageof 18
Annals of Surgical Oncology|May 22, 2020
Contralateral Axillary Lymph Node Metastases from Breast Carcinoma: Is it Time to Review TNM Cancer Staging?Francesca Magnoni, M Colleoni, D Mattar, et al.
British Journal of Cancer|August 23, 2007
Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancerR Torrisi, V Bagnardi, G Pruneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptorsM Colleoni, I Minchella, G Mazzarol, et al.
Breast Cancer Research and Treatment|April 3, 2012
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancerElisabetta Munzone, E Botteri, A Sciandivasci, et al.
ESMO Open|October 16, 2025
Real-world safety and efficacy profiles of trastuzumab deruxtecan in patients with advanced breast cancerG Antonarelli, M Milano, C Andreon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2009
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancerM Colleoni, V Bagnardi, N Rotmensz, et al.
British Journal of Cancer|May 29, 2008
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancerE Montagna, V Bagnardi, N Rotmensz, et al.
Annals of Surgical Oncology|December 18, 2014
Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of OncologyM Intra, G Viale, J Vila, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levelsM Colleoni, A Rocca, M T Sandri, et al.
Breast Cancer Research and Treatment|November 9, 2011
Prognostic role of CA15.3 in 7942 patients with operable breast cancerM T Sandri, M Salvatici, E Botteri, et al.
Pageof 18